je.st
news
Tag: drug
Premarket Biotech Digest: Novartis Earnings, Portola Lawsuits, Celgene's Orphan Drug
2015-07-23 11:13:42| Biotech - Topix.net
Xarelto, Eliquis and other anticoagulants that face products liability lawsuits have made deals with Portola, which is developing an antidote. One of the first anticoagulants, warfarin, was used as rat poison for 50 years before it began life as a blood thinner - and the only reason it did that was because a US Army sergeant who tried to kill himself with it was cured when treated with Vitamin K. Moral of the story- if you want to develop an anticoagulant, you better also develop its antidote, or you could bungle your way into multiple lawsuits.
Tags: drug
earnings
digest
biotech
Eli Lilly: Experimental Alzheimer's drug shows some benefit
2015-07-22 18:23:41| Biotech - Topix.net
Eli Lilly & Co. reported Wednesday that an experimental medication might slow mild Alzheimer's if people take it early enough, one of a handful of drugs in late-stage testing in the frustrating hunt for a better treatment.
Tags: shows
benefit
drug
experimental
Eli Lilly: Experimental Alzheimer's Drug Shows Some Benefit
2015-07-22 16:23:36| Biotech - Topix.net
Eli Lilly & Co. is reporting that its experimental medication might slow mild Alzheimer's if people take it early enough, one of a handful of drugs in late-stage testing in the frustrating hunt for a better treatment.
Tags: shows
benefit
drug
experimental
Our Opinion: The good fight on high prescription drug prices
2015-07-22 06:51:19| Biotech - Topix.net
The high price of prescription medications is a problem many Americans are resigned to. But a quarter of a million dollars? That is the annual price per patient that Boston-based Vertex Pharmaceuticals plans to charge for its new class of breakthrough drugs for the treatment of cystic fibrosis, an obstructive lung disease.
Tags: good
high
prices
opinion
Court ruling clears way for Novartis' low-cost biotech drug
2015-07-21 22:41:33| Biotech - Topix.net
A federal appeals court has ruled that Novartis can begin selling its lower-cost copy of an Amgen Inc. drug in September, rejecting a bid to further delay the launch of the knock-off biotech medication. Novartis received federal approval in March to sell its cheaper copy of Amgen's Neupogen, which is used to boost blood cells in cancer patients.
Tags: court
drug
ruling
biotech
Sites : [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] next »